Similarly, high CTHRC1 expression was implicated in a shorter OS (P < 0.0001), PFS (P < 0.0001) and PPS (P = 0.00049) of patients with ovarian cancer (Fig. 3d). This evidence concerns the gene CTHRC1 and ovarian cancer.